Saturday, May 29, 2021

AlleyWatch

AlleyWatch


Aetion Raises Another $112M to Empower the Healthcare Industry with Data to Make Informed Decisions and Reduce the Time to Market

Posted: 28 May 2021 09:27 AM PDT

While the growth of big data and analytics help businesses understand their customers, serve better ads, and sell more, in healthcare, these same methodologies and technologies have a real enduring, profound societal impact. Real-world data (RW) and real-world evidence (RWE), made possible by technology, are being used by pharmaceutical companies and the healthcare ecosystem to develop, evaluate, implement, and optimize new treatment approaches. Aetion is the RWD and RWE platform that enables the healthcare system to harness the power of data to shape the future of medicine. The platform is designed to accelerate the time to market without compromising scientific rigor. For example, the company partnered with the FDA to develop real-world analytics related to COVID and vaccines. AlleyWatch caught up with CEO Carolyn Magill to learn more about Aetion's approach to RWD is enabling the healthcare system to make informed decisions, the company's strategic, plans, latest round of funding, and much, much more.

No comments:

Post a Comment

guest post needed

Hi I hope you're doing well. I'm reaching out to discuss the possibility of publishing articles on your website. Along with guest ...